LungBlog

U.S. Senator Chuck Hagel (R-NE) and Senator Hillary Rodham Clinton (D-NY) re-introduced a resolution today calling on the President to declare lung cancer a national public health priority by increasing funding for lung cancer research, developing early detection lung cancer screening programs and appointing an advisory committee to oversee and coordinate efforts to reduce lung cancer mortality rates. Hagel and Clinton introduced a similar resolution in the 109th Congress.

Advanced age and other factors predispose patients to respiratory infections after lung cancer surgery, according to a report in the January Journal of Thoracic Oncology.

News of a prototype breath test that could one day be used to detect lung cancer when the disease is at its most treatable has been cautiously welcomed by Cancer Research UK.

The device, which is inexpensive to produce and is around the size of a coin, is not yet reliable enough for clinical use, however, achieving a 75 per cent accuracy rate in trials.

If your co-workers love smoking at the workplace, you better be careful for a new study says that secondhand smoke at the workplace doubles the risk of lung cancer in nonsmokers.

There are greeting cards, it seems, for every occasion, every plot turn in life. Now there’s even a line of cards for those with cancer.

A simple breath test can sometimes detect lung cancer in patients even in the early stages of the disease, proving in principle that the idea might work, U.S. researchers reported.

This year in the U.S more than 200-thousand men and women will be diagnosed with lung cancer.

A biopsy is needed to confirm the diagnosis and extent of the disease.

Now a new tool can provide those answers without surgery.

Doctors jnow about one-third of their patients will die because their lung cancer returns, but they have no way to know which ones. Now, a new kind of test may tell them.

Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).

More women die each year from lung cancer than from breast, ovarian, and cervical cancers combined.  And women who smoke are more likely than men to develop lung cancer. Even women who’ve never smoked are at greater risk than their male counterparts.  Screening for lung cancer hasn’t yet become common, but recent studies suggest that a test called spiral computed tomography can detect lung cancer when it is still curable.